Everjoy Health Group Co., Ltd. (002162.SZ)
CNY 4.12
(-5.72%)
CNY 4.12
(-5.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.27 Billion | 1.16 Billion | 1.26 Billion | 1.19 Billion | 1.16 Billion | 977.87 Million |
| Cost of Revenue | 991.28 Million | 911.62 Million | 921.05 Million | 856.58 Million | 759.23 Million | 638.95 Million |
| Gross Profit | 286.85 Million | 251 Million | 339.77 Million | 338.11 Million | 407 Million | 338.92 Million |
| Operating Expenses | 264.24 Million | 258.76 Million | 256.89 Million | 234.95 Million | 303.21 Million | 264.01 Million |
| Selling, General and Administrative Expenses | 250.67 Million | 242.46 Million | 235.66 Million | 216.64 Million | 286.96 Million | 248.47 Million |
| Research and Development Expenses | 10.2 Million | 11.68 Million | 13.47 Million | 13.17 Million | 9.72 Million | 10.2 Million |
| Other Expenses | -20.3 Million | 4.6 Million | 7.74 Million | 5.14 Million | 6.52 Million | -3.84 Million |
| Cost and Expenses | 1.23 Billion | 1.17 Billion | 1.17 Billion | 1.09 Billion | 1.06 Billion | 902.96 Million |
| Operating Income | 42.14 Million | -23.38 Million | 103.29 Million | 123.55 Million | 126.94 Million | 34.38 Million |
| Interest Expense | 27.74 Million | 30.06 Million | 34.15 Million | 37.14 Million | 45.16 Million | 41.52 Million |
| Income Tax Expense | -8.61 Million | -19.95 Million | 17.74 Thousand | 9.88 Million | 15.94 Million | 8.13 Million |
| Earnings before Tax | 39.42 Million | -300.83 Million | 47.78 Million | 66.99 Million | 53.01 Million | 30.53 Million |
| Net Income | 50.06 Million | -280.88 Million | 46.17 Million | 57.19 Million | 37.87 Million | 24.34 Million |
| Earnings Per Share Basic | 0.05 | -0.30 | 0.05 | 0.07 | 0.04 | 0.03 |
| Earnings Per Share Diluted | 0.05 | -0.30 | 0.05 | 0.07 | 0.04 | 0.03 |
| Weighted Average Shares Outstanding | 927.1 Million | 926.5 Million | 889.61 Million | 853.77 Million | 852.98 Million | 854.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 927.1 Million | 926.5 Million | 889.61 Million | 853.77 Million | 852.98 Million | 854.28 Million |
| Gross Margin | 0.22 | 0.22 | 0.27 | 0.28 | 0.35 | 0.35 |
| EBIT Margin | 0.11 | 0.04 | 0.14 | 0.15 | 0.17 | 0.16 |
| Profit Margin | 0.04 | -0.24 | 0.04 | 0.05 | 0.03 | 0.02 |
| EBITDA | 146.55 Million | -179.9 Million | 170.8 Million | 176.28 Million | 166.17 Million | 139.16 Million |
| Earnings Before Tax Margin | 0.03 | -0.02 | 0.08 | 0.10 | 0.11 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 330.37 Million | 334.39 Million | 218.69 Million | 1.27 Billion | 339.82 Million | 371 Million |
| Cost of Revenue | 271.6 Million | 255.01 Million | 174.17 Million | 991.28 Million | 273.31 Million | 293.12 Million |
| Gross Profit | 58.76 Million | 79.38 Million | 44.52 Million | 286.85 Million | 66.5 Million | 77.88 Million |
| Operating Expenses | 77.03 Million | 53.96 Million | 53.7 Million | 264.24 Million | 79.5 Million | 65.43 Million |
| Selling, General and Administrative Expenses | 71.34 Million | 46.71 Million | 52.23 Million | - | 76.97 Million | 60.62 Million |
| Research and Development Expenses | 2.16 Million | 2.21 Million | 1.47 Million | - | 2.3 Million | 3.61 Million |
| Other Expenses | 3.51 Million | -5.02 Million | 395.4 Thousand | -2.72 Million | -3.06 Million | -259.76 Thousand |
| Cost and Expenses | 348.64 Million | 308.97 Million | 227.88 Million | 1.25 Billion | 352.81 Million | 358.55 Million |
| Operating Income | -38.03 Million | 25.42 Million | -9.18 Million | 42.14 Million | -54.83 Million | -80.8 Million |
| Interest Expense | 6.11 Million | 6.14 Million | 5.93 Million | 27.04 Million | 6 Million | 6.46 Million |
| Income Tax Expense | -1.24 Million | 6.65 Million | 29.74 Thousand | -8.61 Million | 2.24 Million | -21.18 Million |
| Earnings before Tax | -38.14 Million | 25.51 Million | -11.7 Million | 39.42 Million | -57.89 Million | -81.06 Million |
| Net Income | -35.5 Million | 15.44 Million | -13.01 Million | 50.06 Million | -58.78 Million | -59.69 Million |
| Earnings Per Share Basic | -0.04 | 0.02 | -0.01 | - | -0.06 | -0.06 |
| Earnings Per Share Diluted | -0.04 | 0.02 | -0.01 | - | -0.06 | -0.06 |
| Weighted Average Shares Outstanding | 920.3 Million | 925.51 Million | 926.5 Million | 926.5 Million | 926.5 Million | 926.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 920.3 Million | 925.51 Million | 926.5 Million | 926.5 Million | 926.5 Million | 926.5 Million |
| Gross Margin | 0.18 | 0.24 | 0.20 | 0.22 | 0.20 | 0.21 |
| EBIT Margin | -0.10 | 0.13 | -0.04 | - | -0.08 | 0.04 |
| Profit Margin | -0.11 | 0.05 | -0.06 | 0.04 | -0.17 | -0.16 |
| EBITDA | -32.03 Million | 43.86 Million | -7.83 Million | - | -27.14 Million | 13.91 Million |
| Earnings Before Tax Margin | -0.12 | 0.08 | -0.04 | 0.03 | -0.16 | -0.22 |
CNH
300451
2M6
AARTIPHARM
SELAN
UNH